Press Releases
Official numbers released to the market confirm preliminary results - 184% YoY Growth, and this through one of the toughest periods all of us are experiencing. In addition, the full-year forecast has been upgraded to exceed initial predictions. All thanks...
Read Now
YOKNEAM, Israel, May 5, 2021 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced consolidated financial results for its first quarter ended March 31, 2021. First Quarter 2021 Highlights: Quarterly revenues of $65.5 million, an increase...
Read Now
AKE FOREST, Calif., Nov. 10, 2020 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is pleased to share a groundbreaking peer reviewed study, Plume Effect of Fractional Radiofrequency Versus Laser Resurfacing: Considerations in the COVID Pandemic, published in...
Read Now
We are extremely pleased to announce that the US Patent and Trademark Office has granted to InMode Patent No. 10.799.285 covering its Morphues8 full body fractional radiofrequency (RF) technology.
Read Now
INMODE INTRODUCES MORPHEUS 8 BODY WITH MULTI-PULSE BURST TECHNOLOGY. Sydney, Australia, October 23rd, 2020 - InMode Ltd (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, is pleased to introduce to the market the Morpheus8 Body Multi-pulse Burst Radiofrequency...
Read Now